The S&P 500 gained 0.1% on Thursday, July 24, 2025, notching an all-time closing high for the fourth straight day following ...

Investors were clearly impressed by the company's second-quarter beats, especially the one on the bottom line.

It also heralded a change in strategy, with CEO Robert Davis saying that the company is undergoing "a multiyear optimization ...

The 15 percent tariff rate agreed under the new deal could significantly impact pharma firms reliant on European imports.

The S&P 500 and Nasdaq traded near all-time highs at midday as a strong earnings report from Alphabet lifted big tech stocks.

The first oral pill for obstructive sleep apnea could be around the corner after company Apnimed reported positive results from its stage III clinical trial.

Shares in Danish drugmaker Novo Nordisk were down nearly 20% in pre-market trading Tuesday morning after the company cuts its sales and profit estimates.

Eli Lilly's biggest growth driver, tirzepatide, will continue facing scrutiny from investors and analysts. The company's oral ...

The Trump administration has pledged to curb rising obesity with school meal reforms and artificial dye bans, though the ...

Oscar Health (NYSE: OSCR) built on its profitable start to 2025 with a strong first quarter, though emerging challenges in Q2 ...

Trump’s EU trade deal exposes the media’s April tariff freakout—predictions of empty shelves, recession, and market collapse ...

A domestic and international spotlight on tumors In its initial research collaboration with Mass General Brigham, Biostate AI is focusing on melanoma immunotherapy. Specifically, the team's work on ...